Progress of research and application of Heyndrickxia coagulans (Bacillus coagulans) as probiotic bacteria
- PMID: 38863834
- PMCID: PMC11165213
- DOI: 10.3389/fcimb.2024.1415790
Progress of research and application of Heyndrickxia coagulans (Bacillus coagulans) as probiotic bacteria
Abstract
Probiotics are defined as living or dead bacteria and their byproducts that maintain the balance of the intestinal microbiome. They are non-toxic, non-pathogenic, and do not release any toxins either within or outside the body. Adequate consumption of probiotics can enhance metabolite production, increase immunity, maintain a balanced intestinal flora, and stimulate growth. Probiotics do not have negative antibiotic effects and help maintain the natural flora in animals in a balanced state or prevent dysbacteriosis. Heyndrickxia coagulans (H. coagulans) is a novel probiotic species that is gradually being used for the improvement of human health. Compared to commonly used probiotic lactic acid bacteria, H. coagulans can produce spores, which provide the species with high resistance to adverse conditions. Even though they are transient residents of the gut, beneficial bacteria can have a significant impact on the microbiota because they can outnumber harmful germs, and vice versa. This article discusses the probiotic mechanisms of H. coagulans and outlines the requirements for a substance to be classified as a probiotic. It also addresses how to assess strains that have recently been discovered to possess probiotic properties.
Keywords: Heyndrickxia coagulans; probiotic functions; probiotics; safety assessment; secondary metabolism.
Copyright © 2024 Liang, Li, Chen, Guo, Dou, Wang and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Unveiling the influence of a probiotic combination of Heyndrickxia coagulans and Lacticaseibacillus casei on healthy human gut microbiota using the TripleSHIME® system.Microbiol Res. 2024 Aug;285:127778. doi: 10.1016/j.micres.2024.127778. Epub 2024 May 28. Microbiol Res. 2024. PMID: 38823185
-
Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice.Microbiol Spectr. 2022 Aug 31;10(4):e0064122. doi: 10.1128/spectrum.00641-22. Epub 2022 Jul 28. Microbiol Spectr. 2022. PMID: 35900082 Free PMC article.
-
In-silico analysis of probiotic attributes and safety assessment of probiotic strain Bacillus coagulans BCP92 for human application.Lett Appl Microbiol. 2024 Jan 2;77(1):ovad145. doi: 10.1093/lambio/ovad145. Lett Appl Microbiol. 2024. PMID: 38148133
-
Bacillus coagulans and its applications in medicine.Benef Microbes. 2019 Jul 10;10(6):679-688. doi: 10.3920/BM2019.0016. Epub 2019 Jun 17. Benef Microbes. 2019. PMID: 31203635 Review.
-
Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization.Probiotics Antimicrob Proteins. 2018 Dec;10(4):611-615. doi: 10.1007/s12602-017-9354-y. Probiotics Antimicrob Proteins. 2018. PMID: 29196920 Free PMC article. Review.
Cited by
-
Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens.Gut Microbes. 2025 Dec;17(1):2519696. doi: 10.1080/19490976.2025.2519696. Epub 2025 Jun 18. Gut Microbes. 2025. PMID: 40530826 Free PMC article. Review.
-
Clinical and In Vitro Safety of Heyndrickxia coagulans AO 1167B: A Double-Blind, Placebo-Controlled Trial.Microorganisms. 2024 Dec 13;12(12):2584. doi: 10.3390/microorganisms12122584. Microorganisms. 2024. PMID: 39770785 Free PMC article.
-
Oral administration of probiotic spores-based biohybrid system for efficient attenuation of Salmonella Typhimurium-induced colitis.J Nanobiotechnology. 2025 May 26;23(1):378. doi: 10.1186/s12951-025-03468-x. J Nanobiotechnology. 2025. PMID: 40414932 Free PMC article.
-
Heyndrickxia coagulans SANK70258 supplementation improves growth performance, gut health, and liver function in growing pigs.Front Vet Sci. 2025 May 27;12:1537913. doi: 10.3389/fvets.2025.1537913. eCollection 2025. Front Vet Sci. 2025. PMID: 40496914 Free PMC article.
-
Lipoteichoic Acid from Heyndrickxia coagulans HOM5301 Modulates the Immune Response of RAW 264.7 Macrophages.Nutrients. 2024 Sep 6;16(17):3014. doi: 10.3390/nu16173014. Nutrients. 2024. PMID: 39275329 Free PMC article.
References
-
- Anaya-Loyola M. A., Enciso-Moreno J. A., López-Ramos J. E., García-Marín G., Orozco Álvarez M. Y., Vega-García A. M., et al. . (2019). Bacillus coagulans GBI-30, 6068 decreases upper respiratory and gastrointestinal tract symptoms in healthy Mexican scholar-aged children by modulating immune-related proteins. Food Res. Int. 125, 108567. doi: 10.1016/j.foodres.2019.108567 - DOI - PubMed
-
- Aulitto M., Strazzulli A., Sansone F., Cozzolino F., Monti M., Moracci M., et al. . (2021). Prebiotic properties of Bacillus coagulans MA-13: production of galactoside hydrolyzing enzymes and characterization of the transglycosylation properties of a GH42 β-galactosidase. Microb. Cell Fact 20, 71. doi: 10.1186/s12934-021-01553-y - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources